Goldman Sachs senior biotechnology analyst in global investment research Chris Shibutani joins Market Domination Hosts Julie ...

Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Super Micro stock surges, and ...

With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to ...

In a previous interview, Lee hinted that a period of market volatility is expected, as 2024 heads for a soft landing.

The major U.S. stock market indexes are officially in overheated territory thanks to enthusiasm for artificial intelligence ...

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Here are some of the major companies whose stocks moved on the week’s news.

Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer (PFE – Research Report), with a price ...